Join
Live feed
·
INSIDERFilingvia Quantisnow
Syndax Pharmaceuticals Inc. logo

Goldan Keith A. acquired $36,227 worth of shares (2,045 units at $17.72) and was granted 46,700 shares, increasing direct ownership by 1,855% to 51,373 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNDX (Syndax Pharmaceuticals Inc.) and more on Quantisnow.